Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Z-Endoxifen as a Hormonal Therapy for Breast Cancer

NCT01327781 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01327781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01327781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Z-Endoxifen as a Hormonal Therapy for Breast Cancer
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Active, not recruiting
Start date
March 25, 2011
Completion date
October 30, 2026
Enrollment
62 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

her2/neu positive, recurrent breast carcinoma, stage iiic breast cancer ajcc v7, stage iv breast cancer ajcc v6 and v7